TAHO Pharma

TAHO Pharmaceuticals Ltd., founded in 2010 and headquartered in Taipei, Taiwan, is a publicly listed company on the Taipei Exchange. Our company specializes in innovative drug delivery technologies, developing transdermal and transmucosal solutions that enhance drug absorption, improve patient compliance, and optimize therapeutic outcomes.TAHO’s core strategy centers on 505(b)(2) drug development, reformulating established APIs into innovative dosage forms while maintaining comparable pharmacokinetic and therapeutic profiles to branded reference products. Our multi-layer delivery platform is designed to improve stability, bioavailability consistency, and patient usability.